June 7, 2023

Global ” Companion Diagnostics Market ” (2023-2030) report provides a key analysis of the market status with the best facts and figures, SWOT analysis, expert opinions, and the latest developments around the world. The report assesses the present market scenario and identifies emerging trends that could influence Companion Diagnostics Market growth and revenue.

The report will be remarkable in its ability to provide worldwide investors with the information they need to make informed judgments about the market. This report is based on a variety of secondary and primary sources to present a comprehensive and accurate picture of the Companion Diagnostics Market.

Get a Free Sample Research PDF of Report:



The global Companion Diagnostics Market size was valued at USD 6.80 billion in 2021. The market is projected to grow from USD 7.67 billion in 2022 to USD 15.91 billion by 2029, exhibiting a CAGR of 11.0% during the forecast period.


Companion Diagnostics Market Drivers :

The prevalence of cancer is increasing significantly in recent years. The growing prevalence of cancer cases increases the need for effective CDx assays as genomic testing provides a clear picture of patients’ tumors and offers precise insights to doctors about treatment protocols. Thus, the increasing prevalence of cancer is increasing the sales of products of CDx.According to Canadian cancer statistics, in November 2021, 229,200 new cancer cases were diagnosed in Canada.Also, according to the World Health Organization (WHO), in 2022, there were 2.26 million new cases of people diagnosed with breast cancer and 2.21 million issues of people diagnosed with lung cancer worldwide.Moreover, to fulfill an increasing need, novel tests are being developed to diagnose specific types of mutations.In August 2020, the U.S. FDA approved Guardant360 CDx. This first liquid biopsy companion diagnostic uses Next-Generation Sequencing (NGS) technology to identify patients with a specific types of mutations of the Epidermal Growth Factor Receptor (EGFR) gene in metastatic Non-Small Cell Lung Cancer (NSCLC).This factor has led to global demand for these tests and is responsible for the market’s growth during the forecast duration.

Research Methodology:

The future growth trends of the industry are explored based on a rapid quantitative and qualitative assessment of data gathered from various sources. The authors have used wide and organized research techniques to encompass every aspect of the Companion Diagnostics Market. Secondary sources include the verification of important documents such as annual reports, press releases, trade association data, case studies, third-party data providers, and others.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Companion Diagnostics Market.

Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Some of the Major Players Operating in the Companion Diagnostics Market:

  • Abbott (U.S.)
  • F. Hoffmann-La Roche Ltd.(Switzerland)
  • Agilent Technologies, Inc.(U.S.)
  • Illumina, Inc. (U.S.)
  • Guardant Health (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • BIOMERIEUX (France)
  • QIAGEN (Germany)
  • Myriad Genetics, Inc. (U.S.)

Ask For Customization:


Report Highlights

The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain.

The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies

Global Segmentation:

The Companion Diagnostics Market is segmented on the basis of type, fiber type, application, tow size, modulus and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Complete Overview of this Industry:

Providing a complete overview of the global Companion Diagnostics Market, as there are many different markets and industries around the world. However, I can provide a high-level summary of some of the key trends and factors that are currently impacting the Companion Diagnostics Market. Economic Growth, Technology, E-commerce, Globalization, Sustainability, Demographics, and regulatory risks are just a few of the many factors that are currently shaping the global market.

Table of Contents

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Companion Diagnostics Market Size 2023
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Companion Diagnostics Market Trends 2023
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment 2023
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of the Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News 2023
4.2.1 Key Product Launch News
4.2.2 Companion Diagnostics Market Expansion Plans

5 Analysis of Leading Companies

TOC Continued……

Purchase Full Report at –


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

Email: [email protected]

Phone: US:+1 424 253 0390, UK: +44 2071 939123, APAC: +91 744 740 1245


Related Reports :

Neonatal Care Equipment Market

Smart Hospitals Market

Audiology Devices Market

Human Platelet Lysate Market

Continuous Positive Airway Pressure Masks Market

Companion Animal Healthcare Market

Europe Diet Pills Market

Stereotactic Body Radiation Therapy Market

Veterinary Equipment and Disposables Market

U.S. Dialysis Services Market